- New
Monitoring cancer with repeat biomarker testing
Wondering why your doctor recommends another biomarker test? Discover how repeat testing helps monitor treatment, detect changes, and guide the next steps.
6 min read
Key takeaways
Why biomarker testing may be repeated
Cancer cells can adapt and evolve. Even if your treatment worked well at first, cancer cells may develop resistance, making the therapy less effective. Repeat biomarker testing can help your care team stay on top of these changes by:
- Tracking treatment response: For certain cancers, are biomarker levels decreasing as expected? If not, it may signal that the cancer isn’t responding. You and your care team can discuss other therapies or approaches.
- Detecting new mutations: Cancer can develop new genetic changes that affect how it behaves and responds to drugs. Repeat biomarker testing can be useful in helping to figure out if a new or different targeted therapy could be more effective in treating your type of cancer
- Identifying recurrence early: If cancer returns after remission, repeat testing can reveal important clues about its current profile.
- Exploring new treatment options: Advances in cancer therapy happen quickly. Repeat testing can show whether you qualify for newer targeted drugs or immunotherapies.
- Opening doors to clinical trials: Many trials require specific biomarkers. Updated testing can help ensure you don’t miss opportunities for investigational treatments.
Repeating biomarker tests can be an important part of precision care. Knowing that your cancer is being closely monitored can reduce uncertainty and help you feel more confident about your treatment plan.
Repeating biomarker tests can be an important part of precision care.
How repeat biomarker testing is done
Just like biomarker tests that happen after diagnosis, repeat biomarker testing can be performed in two ways:
- Tissue biopsy: This involves removing a small sample of tissue from an individual tumor for analysis. It provides detailed information about the cancer’s genetic and molecular profile. Although it does require a procedure with local anesthesia and a recovery period, tissue biopsies are the gold standard and can provide a great amount of information about your cancer.
- Liquid biopsy: This is a test that looks at blood or another body fluid, such as saliva or urine, for fragments of tumor DNA or other biomarkers circulating in the bloodstream. Liquid biopsies are less invasive, can be repeated more frequently than tissue biopsies, and can provide quicker results. They are especially useful for monitoring changes over time and can be used to capture information if there are multiple tumor sites. However, they aren’t considered the gold standard, as they are generally less sensitive than tissue biopsies and may not provide the same level of detail.
These two types of biopsies give doctors a clearer picture of how your cancer is evolving and if there is a need to take a different approach or begin you on a new targeted therapy.
Repeat biomarker testing is designed to provide critical insights. Whether through a blood draw, liquid collection, or tissue sample, these tests help ensure your treatment plan can be adapted to address any changes that may occur.
Benefits of repeat biomarker testing
Repeat biomarker testing doesn’t always lead to a change in treatment, and all biomarkers aren’t directly tied to specific therapies. Even so, checking them over time can reveal important shifts in how your cancer is behaving, and when meaningful changes do appear, they can support the following aspects of your care:
- Tracking treatment effectiveness: By understanding how your cancer is responding, doctors can make appropriate adjustments, whether that means continuing your current therapy, changing the dose, or switching to a new treatment.
- Identifying treatment resistance: Cancer can develop resistance to certain drugs over time. Repeat testing helps identify these changes early, so your care team can act in a timely manner.
- Accessing clinical trials: Many clinical trials require specific biomarkers for eligibility. Updated testing can help open the door to more opportunities for potential new therapies.
- Detecting recurrence: Even after successful treatment, some cancers can return. Repeat biomarker testing can help spot signs of recurrence even before they appear on scans or cause symptoms. For example, a rise in certain biomarkers may be one of the first clues that cancer cells are active again, giving your doctor the opportunity to intervene sooner.
- Informing precision care: Biomarker trends allow your doctor to tailor treatment to your cancer’s unique characteristics, rather than relying on a one-size-fits-all approach.
Interpreting results and next steps
Biomarker trends tell a story about how your cancer is behaving and responding to treatment. Here’s what those changes can mean:
- Stable or decreasing levels: This may suggest your treatment is working as intended. Your doctor may recommend continuing the current therapy.
- Rising levels: This can indicate that the cancer is becoming resistant to treatment or that it has returned. Detecting this early allows your care team to act quickly.
- New biomarkers detected: Sometimes, repeat testing reveals new genetic changes. These may open the door to different targeted therapies or clinical trials.
Your doctor will review the results and discuss options such as:
- Adjusting your current treatment
- Switching to a new therapy that targets the updated biomarkers
- Considering clinical trial enrollment
Biomarker results can be complex. Always ask your care team to explain what the results mean for your specific situation. This discussion guide will help you prepare questions to ask your doctor. Understanding the next steps can help you feel more informed about your treatment plan.
Be informed about repeat biomarker testing and what it means for your care plan
Every biomarker test provides valuable insight into your cancer’s journey and your path forward. By staying informed and asking questions, you can play an active role in your treatment journey.
Staying informed:
- Empowers you to make decisions: Knowing what your results mean helps you feel confident about next steps.
- Improves communication with your doctor: When you understand the purpose of repeat testing, you can ask better questions and advocate for your needs.
- Keeps your care personalized: Biomarker trends guide treatment choices tailored to your cancer’s unique profile.
Ask questions like:
- How often should I have repeat biomarker testing?
- What changes in my results would lead to a treatment adjustment?
- Could these results make me eligible for clinical trials or new therapies?
Read How to talk to your doctor about biomarker testing to help you prepare for your conversation with your care team about repeat biomarker testing and create a personalized discussion guide to help guide your conversation.
A liquid biopsy is a test that looks at blood or another body fluid, such as saliva or urine, for fragments of tumor DNA or other biomarkers circulating in the bloodstream.
Find out more about how biomarker testing works and why it’s key to personalized care:
Correct answer: A liquid biopsy is a test that looks at blood or another body fluid, such as saliva or urine, for fragments of tumor DNA or other biomarkers circulating in the bloodstream.
Find out more about how biomarker testing works and why it’s key to personalized care:
Frequently asked questions
How often should biomarker testing be repeated?
How often biomarker testing is repeated depends on your cancer type and the biomarkers being tracked, your specific treatment plan and goals, and overall health. Some patients may need testing more often, while others only when treatment changes are considered. Your care team will provide guidance on how frequently testing should be done
Is repeat biomarker testing covered by insurance?
Coverage for biomarker testing varies by provider and cancer type. Many plans cover biomarker testing if it is medically necessary.
Are there risks or side effects from biomarker testing
Biomarker testing is generally very safe. Liquid biopsies may cause brief soreness or bruising, similar to regular blood tests. Tissue biopsies can cause mild pain, bleeding, or a small risk of infection. Your care team will explain what to expect and how to care for the biopsy site. Overall, the benefits of testing usually outweigh these risks.
How do I ask my doctor about biomarker testing?
Start a conversation with your doctor by asking if repeat biomarker testing would be helpful. Your doctor can explain if it’s appropriate for your situation
This discussion guide will help you prepare for a discussion with your doctor:
More relevant articles
Keep reading
- New
How to talk to your doctor about biomarker testing
Get help navigating conversations about biomarker testing and personalized treatment plans.
5 min read
- Recommended
The importance of biomarker testing
Learn how biomarker testing can help influence treatment decisions.
5 min read
- New
How biomarker testing works
See what’s involved in the process and what doctors are looking for in test results.
7 min read
- New
When to get biomarker testing for cancer
Did you now that early testing can make a difference in your care?
6 min read
- Recommended
What are cancer biomarkers and what is biomarker testing?
Get the science behind biomarkers and how it can lead to a personalized treatment plan.
6 min read
References
AlDoughaim, Maha et al. Cancer Biomarkers and Precision Oncology: A Review of Recent Trends and Innovations. Clinical Medicine Insights. 2024. doi:10.1177/11795549241298541.
American Cancer Society. Biomarker Tests and Cancer Treatment. September 21, 2022. Accessed December 8, 2025. https://www.cancer.org/cancer/diagnosis-staging/tests/biomarker-tests.html
Fabi et al. HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care. Clin Cancer Res. 2011;17(7):2055-2064.
Henry NL, Hayes DF. Cancer biomarkers. Mol Oncol. 2012;6(2):140-146. doi: 10.1016/j.molonc.2012.01.010.
Liu H, Karsidag I, Golin R, Wu G. Bridging discovery and treatment: cancer biomarker. Cancers (Basel). 2025;17(22):3720. Published 2025 Nov 20. doi:10.3390/cancers17223720.
MedinePlus. Tumor Marker Tests. Accessed December 11, 2025. https://medlineplus.gov/lab-tests/tumor-marker-tests/
National Cancer Institute. Biomarker Testing for Cancer Treatment. Accessed December 8, 2025. https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment
Shen F, Zailaie SA, Chiu B, Magliocco A, Sergi CM. Liquid biopsy - a narrative review with an update on current US governmental clinical trials targeting immunotherapy. Future Sci OA. 2025;11(1):2527598. doi:10.1080/20565623.2025.2527598